BIOCORP: 2020 Financial Calendar

ISSOIRE, France--(BUSINESS WIRE)--Regulatory News:

BIOCORP (FR0012788065 – ALCOR / Eligible PEA PME) (Paris:ALCOR), a French company specialized in the development and manufacturing of medical devices and smart drug delivery systems, updates its financial reporting schedule for 2020^*:

Annonce	Date*
2019 full-year results	Thursday, April 9^th, 2020 Before the market opening
Annual shareholders meeting	Friday, May 15^th, 2020
2020 first-half results	Thursday, September 24^th, 2020 After the market close

^* This schedule is indicative and subject to change.

À PROPOS DE BIOCORP
Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This intelligent sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of diabetics. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 54 employees.
BIOCORP is listed on Alternext since July 2015 (FR0012788065 – ALCOR).
For more information, please visit www.biocorpsys.com
Follow us on Twitter @BIOCORPSystems